ASSERTIO THERAPEUTICS, INC. Realized Gains on Marketable Securities
ASSERTIO THERAPEUTICS, INC. reported Realized Gains on Marketable Securities of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-11.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLoss · last filed 2019-03-11
- ASSERTIO THERAPEUTICS, INC. marketable securities, realized gain (loss) for the quarter ending 2018-12-31 was $0.00.
- ASSERTIO THERAPEUTICS, INC. marketable securities, realized gain (loss) for the quarter ending 2018-09-30 was $0.00.
- ASSERTIO THERAPEUTICS, INC. marketable securities, realized gain (loss) for the quarter ending 2017-12-31 was $0.00.
- ASSERTIO THERAPEUTICS, INC. marketable securities, realized gain (loss) for the quarter ending 2017-09-30 was $0.00.
- ASSERTIO THERAPEUTICS, INC. marketable securities, realized gain (loss) for fiscal 2018 was $0.00.
- ASSERTIO THERAPEUTICS, INC. marketable securities, realized gain (loss) for fiscal 2017 was $0.00.
- ASSERTIO THERAPEUTICS, INC. marketable securities, realized gain (loss) for fiscal 2016 was $0.00.
| Period end | Marketable Securities, Realized Gain (Loss) 3 month | Marketable Securities, Realized Gain (Loss) 6 month | Marketable Securities, Realized Gain (Loss) 9 month | Marketable Securities, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $0.00 derived: sum of 2 quarters · filed 2019-03-11 | $0.00 10-K · filed 2019-03-11 | |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | ||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $0.00 derived: sum of 2 quarters · filed 2019-03-11 | $0.00 10-K · filed 2019-03-11 | |
| 2017-09-30 | $0.00 10-Q · filed 2018-11-09 | $0.00 10-Q · filed 2018-11-09 | ||
| 2016-12-31 | $0.00 10-K · filed 2019-03-11 |